View in EDS HTML Full Text PDF Full Text

Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia.

Saved in:
Bibliographic Details
Title: Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia.
Authors: Bell CC; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Fennell KA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Chan YC; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Rambow F; Laboratory for Molecular Cancer Biology, VIB Center for Cancer Biology, KU Leuven, Leuven, Belgium., Yeung MM; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Vassiliadis D; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Lara L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Yeh P; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Martelotto LG; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia., Rogiers A; Laboratory for Molecular Cancer Biology, VIB Center for Cancer Biology, KU Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium., Kremer BE; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Barbash O; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Mohammad HP; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Johanson TM; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Burr ML; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Dhar A; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Karpinich N; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Tian L; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Tyler DS; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., MacPherson L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Shi J; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Pinnawala N; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Yew Fong C; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Papenfuss AT; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Grimmond SM; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia., Dawson SJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia., Allan RS; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Kruger RG; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Vakoc CR; Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA., Goode DL; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Naik SH; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Gilan O; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Lam EYN; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Marine JC; Laboratory for Molecular Cancer Biology, VIB Center for Cancer Biology, KU Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium., Prinjha RK; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Dawson MA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. Mark.Dawson@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia. Mark.Dawson@petermac.org.; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. Mark.Dawson@petermac.org.; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia. Mark.Dawson@petermac.org.
Source: Nature communications [Nat Commun] 2019 Jun 20; Vol. 10 (1), pp. 2723. Date of Electronic Publication: 2019 Jun 20.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31222014
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bell+CC%22">Bell CC</searchLink>; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Fennell+KA%22">Fennell KA</searchLink>; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Chan+YC%22">Chan YC</searchLink>; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Rambow+F%22">Rambow F</searchLink>; Laboratory for Molecular Cancer Biology, VIB Center for Cancer Biology, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Yeung+MM%22">Yeung MM</searchLink>; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Vassiliadis+D%22">Vassiliadis D</searchLink>; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Lara+L%22">Lara L</searchLink>; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Yeh+P%22">Yeh P</searchLink>; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Martelotto+LG%22">Martelotto LG</searchLink>; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Rogiers+A%22">Rogiers A</searchLink>; Laboratory for Molecular Cancer Biology, VIB Center for Cancer Biology, KU Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Kremer+BE%22">Kremer BE</searchLink>; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Barbash+O%22">Barbash O</searchLink>; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Mohammad+HP%22">Mohammad HP</searchLink>; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Johanson+TM%22">Johanson TM</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Burr+ML%22">Burr ML</searchLink>; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Dhar+A%22">Dhar A</searchLink>; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Karpinich+N%22">Karpinich N</searchLink>; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Tian+L%22">Tian L</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Tyler+DS%22">Tyler DS</searchLink>; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22MacPherson+L%22">MacPherson L</searchLink>; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Shi+J%22">Shi J</searchLink>; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.<br /><searchLink fieldCode="AU" term="%22Pinnawala+N%22">Pinnawala N</searchLink>; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Yew+Fong+C%22">Yew Fong C</searchLink>; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Papenfuss+AT%22">Papenfuss AT</searchLink>; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Grimmond+SM%22">Grimmond SM</searchLink>; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Dawson+SJ%22">Dawson SJ</searchLink>; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Allan+RS%22">Allan RS</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Kruger+RG%22">Kruger RG</searchLink>; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Vakoc+CR%22">Vakoc CR</searchLink>; Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA.<br /><searchLink fieldCode="AU" term="%22Goode+DL%22">Goode DL</searchLink>; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Naik+SH%22">Naik SH</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Gilan+O%22">Gilan O</searchLink>; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Lam+EYN%22">Lam EYN</searchLink>; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Marine+JC%22">Marine JC</searchLink>; Laboratory for Molecular Cancer Biology, VIB Center for Cancer Biology, KU Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Prinjha+RK%22">Prinjha RK</searchLink>; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Dawson+MA%22">Dawson MA</searchLink>; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. Mark.Dawson@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia. Mark.Dawson@petermac.org.; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. Mark.Dawson@petermac.org.; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia. Mark.Dawson@petermac.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2019 Jun 20; Vol. 10 (1), pp. 2723. <i>Date of Electronic Publication: </i>2019 Jun 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31222014
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-019-10652-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2723
    Titles:
      – TitleFull: Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bell CC
      – PersonEntity:
          Name:
            NameFull: Fennell KA
      – PersonEntity:
          Name:
            NameFull: Chan YC
      – PersonEntity:
          Name:
            NameFull: Rambow F
      – PersonEntity:
          Name:
            NameFull: Yeung MM
      – PersonEntity:
          Name:
            NameFull: Vassiliadis D
      – PersonEntity:
          Name:
            NameFull: Lara L
      – PersonEntity:
          Name:
            NameFull: Yeh P
      – PersonEntity:
          Name:
            NameFull: Martelotto LG
      – PersonEntity:
          Name:
            NameFull: Rogiers A
      – PersonEntity:
          Name:
            NameFull: Kremer BE
      – PersonEntity:
          Name:
            NameFull: Barbash O
      – PersonEntity:
          Name:
            NameFull: Mohammad HP
      – PersonEntity:
          Name:
            NameFull: Johanson TM
      – PersonEntity:
          Name:
            NameFull: Burr ML
      – PersonEntity:
          Name:
            NameFull: Dhar A
      – PersonEntity:
          Name:
            NameFull: Karpinich N
      – PersonEntity:
          Name:
            NameFull: Tian L
      – PersonEntity:
          Name:
            NameFull: Tyler DS
      – PersonEntity:
          Name:
            NameFull: MacPherson L
      – PersonEntity:
          Name:
            NameFull: Shi J
      – PersonEntity:
          Name:
            NameFull: Pinnawala N
      – PersonEntity:
          Name:
            NameFull: Yew Fong C
      – PersonEntity:
          Name:
            NameFull: Papenfuss AT
      – PersonEntity:
          Name:
            NameFull: Grimmond SM
      – PersonEntity:
          Name:
            NameFull: Dawson SJ
      – PersonEntity:
          Name:
            NameFull: Allan RS
      – PersonEntity:
          Name:
            NameFull: Kruger RG
      – PersonEntity:
          Name:
            NameFull: Vakoc CR
      – PersonEntity:
          Name:
            NameFull: Goode DL
      – PersonEntity:
          Name:
            NameFull: Naik SH
      – PersonEntity:
          Name:
            NameFull: Gilan O
      – PersonEntity:
          Name:
            NameFull: Lam EYN
      – PersonEntity:
          Name:
            NameFull: Marine JC
      – PersonEntity:
          Name:
            NameFull: Prinjha RK
      – PersonEntity:
          Name:
            NameFull: Dawson MA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 06
              Text: 2019 Jun 20
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1